Veracyte (VCYT) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $19.1 million.
- Veracyte's Income from Continuing Operations rose 2633.35% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 42692.18%. This contributed to the annual value of $24.1 million for FY2024, which is 13244.18% up from last year.
- As of Q3 2025, Veracyte's Income from Continuing Operations stood at $19.1 million, which was up 2633.35% from -$980000.0 recorded in Q2 2025.
- Over the past 5 years, Veracyte's Income from Continuing Operations peaked at $19.1 million during Q3 2025, and registered a low of -$41.9 million during Q1 2021.
- Over the past 5 years, Veracyte's median Income from Continuing Operations value was -$8.4 million (recorded in 2023), while the average stood at -$7.2 million.
- As far as peak fluctuations go, Veracyte's Income from Continuing Operations plummeted by 63033.04% in 2023, and later soared by 47703.86% in 2025.
- Veracyte's Income from Continuing Operations (Quarter) stood at -$10.5 million in 2021, then skyrocketed by 63.16% to -$3.9 million in 2022, then tumbled by 630.33% to -$28.3 million in 2023, then soared by 118.16% to $5.1 million in 2024, then skyrocketed by 272.53% to $19.1 million in 2025.
- Its Income from Continuing Operations stands at $19.1 million for Q3 2025, versus -$980000.0 for Q2 2025 and $7.0 million for Q1 2025.